News Years after Pfizer merger, ex-Medivation exec gets insider t... A Medivation executive at the heart of the company's team that sold the company to Pfizer for $14 billion five years ago is facing allegations of insider trading.
Views & Analysis Why does UK biotech struggle to generate leaders? Can the UK emulate America's culture of biotech entrepreneurship?
News Takeda earmarks $15 billion for M&A - reports Japanese company could be on the acquisition trail.
News Merck, Pfizer and Gilead all interested in Medivation buy-ou... Sanofi has competition in its bid to acquire cancer specialist
News 23andMe fined £2.31m over UK users' genetic data breach Genetic testing company 23andMe is facing a hefty fine from the UK's data protection watchdog for failing to protect its customers' data.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face